OLUSOLA A AJILORE
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry CHICAGO, IL NPI 1740213347
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry IL Boehringer Ingelheim International GmbH All categories
General Payments — all program years on this page
$20,935.18
- Category: General Payments
- Program years: PY2022–2023
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $13,800.68 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $11,681.42 | 2 |
| Consulting Fee | $1,815.00 | 2 |
| Food and Beverage | $304.26 | 2 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim International GmbH | $11,744.74 | 3 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,350.00 | 1 |
| Sage Therapeutics, Inc. | $705.94 | 2 |
By program year
Records — PY2023 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1014015633 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,350.00 | 05/25/2023 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1017097729 | Sage Therapeutics, Inc. | $465.00 | 01/10/2023 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1017102015 | Sage Therapeutics, Inc. | $240.94 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1017327959 | Boehringer Ingelheim International GmbH | $63.32 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1017327963 | Boehringer Ingelheim International GmbH | $891.70 | 03/24/2023 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1017334997 | Boehringer Ingelheim International GmbH | $10,789.72 | 03/24/2023 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.